Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: -0.50 (-2.50%)
Spread: 1.00 (5.263%)
Open: 19.50
High: 20.00
Low: 19.50
Prev. Close: 20.00
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

1 Aug 2013 07:00

RNS Number : 6660K
Iofina PLC
01 August 2013
 

1 August 2013

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

 

Operational Update

 

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to report that production in the second quarter totaled 45 tonnes of iodine paste compared with 17.5 tonnes in the first quarter, largely as a result of an increase in overall plant runtime from approximately 40% to 80%. The Company also recorded a daily high of over 1000kgs in the second quarter compared with a high of 695kgs in the first quarter.

 

Despite these operational improvements the total available produced water for processing continues to be below forecast at WET® IOsorb™ IO#2 due to temporary disruptions attributable to the operators ongoing drilling and completion programs. Additional new wells are expected to be drilled and tied in in the coming months.

 

In addition, during the month of June, the Company experienced large ingresses of produced oil at WET® IOsorb™ IO#2. This was effectively handled, by the operation team resulting in techniques that will be incorporated into the Company's operation both at WET® IOsorb™ IO#2 and future sites where required. Iodine ppm levels and volumes at WET® IOsorb™ IO#1 continue to improve as well.

 

In July the Company processed at more consistent flow rates than in the previous quarter. This has resulted in a higher daily average of iodine produced. The Board fully expects the production volumes to increase to the previously reported production estimates of 800-900 kilograms per day. The Board anticipates this to occur during the third quarter as the Company improves runtime and efficiencies along with the tie-in of additional wells by the operator. An update on FY guidance will be provided in the interim results.

 

Construction of WET® IOsorb™ IO#3 is ongoing, with completion expected at the end of September. Locations for WET® IOsorb™ IO#4, IO#5 and IO#6 have been selected and procurement of plant equipment is largely complete and site leasing is in progress. The Company has seen increased demand in manufacturing for the energy sector in the US as deliveries for the Company's fibreglass equipment, especially towers, are at least four weeks longer than previously envisaged. An additional set of titanium towers have also been ordered and are currently being fabricated. IO#4, IO#5 and IO#6 are scheduled to complete in the fourth quarter of 2013.

 

Iofina has updated and expanded its Iodine Extraction Agreement with one of the largest independent oil and gas producers in the US, most significantly, now covering four separate locations. In addition, this agreement provides a unique mechanism to rapidly add additional locations providing a growth path for future expansion. Based on the Company's exploration and sampling program, Iofina has already identified several locations beyond the four committed sites. Through this on-going exploration, the Board is pleased to announce the discovery of multiple sites with extremely high iodine concentrations. The Company is developing a unique Hydrosorb processing unit to match the characteristics of these sites. This plant will be able to produce significant volumes of iodine without the expense of processing large water volumes. The Company is also in the process of developing its Mobile and MaxSorb units to meet the needs of additional production profiles.

 

Budgeting for 2014 is being undertaken with planning currently incorporating six additional plants, one every two months.

 

Iofina is also progressing on its Water Depot project. The next step in the Montana Department of Natural Resources and Conservation permitting process is to prepare a detailed engineering report. An engineering firm has been retained to complete this study. This study is anticipated to be completed in mid-August. Finalised agreements for the terminal's physical location, the necessary flow line right of ways, and pump stations have been completed. Additionally, the Company has been in contact with several oil and gas operators, service companies, and trucking companies to obtain additional letters of intent to purchase water.

 

 

For further information, please contact:

 

Dr. Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)20 3006 3135

www.iofina.com

 

Ben Colegrave/Chris Sim/James Rudd

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGURCMUPWPUG
Date   Source Headline
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.